Rare diseases
Investigational molecules
Locations
Back to Belgium1 898 clinical trials in Mechelen, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
BelgiumStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
BelgiumStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
BelgiumStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
BelgiumStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
BelgiumStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
BelgiumStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
BelgiumStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
BelgiumStudy of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
BelgiumStudy on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on respiratory infections and preventive measures, including innovative vaccine trials for RSV and influenza in various age groups. Research encompasses both standalone treatments and combination therapies.
Special attention is given to protecting vulnerable populations, particularly adults over 60 years of age.
Groundbreaking research in lung cancer treatment, particularly focusing on non-small cell and small cell variants. Studies evaluate novel therapeutic approaches including immunotherapy combinations.
Investigations include both first-line treatments and advanced therapy options.
Studies addressing cardiovascular disease and related conditions, including trials for hypertriglyceridemia and stroke prevention in atrial fibrillation patients.
Focus on both preventive measures and treatment of existing conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
